retinoic acid ra Search Results


9-cis retinoic acid (ra; rxrα)  (INDIGO Biosciences)
90
INDIGO Biosciences 9-cis retinoic acid (ra; rxrα)
9 Cis Retinoic Acid (Ra; Rxrα), supplied by INDIGO Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/9+cis+retinoic+acid++ra++rxr%CE%B1+/pmc04180444-53-6-30
Average 90 stars, based on 1 article reviews
9-cis retinoic acid (ra; rxrα) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
all-trans retinoic acid (atra)  (BASF)
90
BASF all-trans retinoic acid (atra)
Characterization of blank NLC and <t> ATRA-loaded </t> NLC (NLC-A and NLC-B) for PCS diameter, polydispersion index and zeta potential.
All Trans Retinoic Acid (Atra), supplied by BASF, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/retinoic+acid++ra+/pmc04634877-95-2-29
Average 90 stars, based on 1 article reviews
all-trans retinoic acid (atra) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
all-trans retinoic acid ra 182–01111  (FUJIFILM)
90
FUJIFILM all-trans retinoic acid ra 182–01111
Characterization of blank NLC and <t> ATRA-loaded </t> NLC (NLC-A and NLC-B) for PCS diameter, polydispersion index and zeta potential.
All Trans Retinoic Acid Ra 182–01111, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/all+trans+retinoic+acid+ra+182+01111/pmc08386610-263-0-29
Average 90 stars, based on 1 article reviews
all-trans retinoic acid ra 182–01111 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
retinoic acid (ra)  (HiMedia Laboratories)
90
HiMedia Laboratories retinoic acid (ra)
Characterization of blank NLC and <t> ATRA-loaded </t> NLC (NLC-A and NLC-B) for PCS diameter, polydispersion index and zeta potential.
Retinoic Acid (Ra), supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/retinoic+acid++ra+/pmc05809655-69-18-28
Average 90 stars, based on 1 article reviews
retinoic acid (ra) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
retinoic acid (ra)  (BLDpharm)
90
BLDpharm retinoic acid (ra)
Characterization of blank NLC and <t> ATRA-loaded </t> NLC (NLC-A and NLC-B) for PCS diameter, polydispersion index and zeta potential.
Retinoic Acid (Ra), supplied by BLDpharm, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/retinoic+acid++ra+/10__46309_slash_biodicon__2023__1344361-80-22-25
Average 90 stars, based on 1 article reviews
retinoic acid (ra) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
alltrans retinoic acid  (FUJIFILM)
90
FUJIFILM alltrans retinoic acid
Characterization of blank NLC and <t> ATRA-loaded </t> NLC (NLC-A and NLC-B) for PCS diameter, polydispersion index and zeta potential.
Alltrans Retinoic Acid, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/retinoic+acid+ra/pm37770475-183-8-14
Average 90 stars, based on 1 article reviews
alltrans retinoic acid - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
retinoic acid ra  (HumanZyme)
90
HumanZyme retinoic acid ra
Direct differentiation of ADPKD-iPSCs into kidney-like cells (KLCs). ( a ) Scheme showing the stepwise protocol used for producing KLCs from ADPKD-iPSCs and the time needed. ( b ) Morphology of induced ADPKD-iPSCs is similar to podocytes and human kidney (HK2) cells. Bar = 100 μm. ( c ) Upregulation of marker genes of each stage during differentiation from iPSCs into functional KLCs. Values (mean of three replicates) are referred to the undifferentiated iPSCs. Data presented as mean ± standard deviation from three independent sets of experiments, * P < 0.05, ** P < 0.01. ( b ) Pluripotency of iPSCs decreased during induction to KLCs. Data are averages and standard deviations of three independent experiments. Values (mean of three replicates) are referred to the undifferentiated iPSCs. ** P < 0.01. ( e ) Immunofluorescence and FCM results of marker genes of each step of induction. BRY is a marker <t>of</t> <t>mesoderm</t> cells; PAX2 a marker for intermesoderm cells; and synaptopodin, AQP1, and E-cadherin (E-CAD) are markers for KLCs. Bar = 50 μm. iPSC induced pluripotent stem cell, RA <t>retinoic</t> acid, REGM renal epithelium growth medium, ABVF Activin-A, BMP7, hVEGF and bFGF
Retinoic Acid Ra, supplied by HumanZyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/retinoic+acid+ra/pmc05606115-174-16-19
Average 90 stars, based on 1 article reviews
retinoic acid ra - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
agonist of rxrα lg000268 (lg268), 9-cis-retinoic acid (9- cis-ra)  (GlpBio Technology Inc)
90
GlpBio Technology Inc agonist of rxrα lg000268 (lg268), 9-cis-retinoic acid (9- cis-ra)
Direct differentiation of ADPKD-iPSCs into kidney-like cells (KLCs). ( a ) Scheme showing the stepwise protocol used for producing KLCs from ADPKD-iPSCs and the time needed. ( b ) Morphology of induced ADPKD-iPSCs is similar to podocytes and human kidney (HK2) cells. Bar = 100 μm. ( c ) Upregulation of marker genes of each stage during differentiation from iPSCs into functional KLCs. Values (mean of three replicates) are referred to the undifferentiated iPSCs. Data presented as mean ± standard deviation from three independent sets of experiments, * P < 0.05, ** P < 0.01. ( b ) Pluripotency of iPSCs decreased during induction to KLCs. Data are averages and standard deviations of three independent experiments. Values (mean of three replicates) are referred to the undifferentiated iPSCs. ** P < 0.01. ( e ) Immunofluorescence and FCM results of marker genes of each step of induction. BRY is a marker <t>of</t> <t>mesoderm</t> cells; PAX2 a marker for intermesoderm cells; and synaptopodin, AQP1, and E-cadherin (E-CAD) are markers for KLCs. Bar = 50 μm. iPSC induced pluripotent stem cell, RA <t>retinoic</t> acid, REGM renal epithelium growth medium, ABVF Activin-A, BMP7, hVEGF and bFGF
Agonist Of Rxrα Lg000268 (Lg268), 9 Cis Retinoic Acid (9 Cis Ra), supplied by GlpBio Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/agonist+of+rxr%CE%B1+lg000268++lg268+++9+cis+retinoic+acid++9++cis+ra+/pm37429055-64-1-17
Average 90 stars, based on 1 article reviews
agonist of rxrα lg000268 (lg268), 9-cis-retinoic acid (9- cis-ra) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
9-cis-retinoic acid ra  (AG Scientific)
90
AG Scientific 9-cis-retinoic acid ra
Direct differentiation of ADPKD-iPSCs into kidney-like cells (KLCs). ( a ) Scheme showing the stepwise protocol used for producing KLCs from ADPKD-iPSCs and the time needed. ( b ) Morphology of induced ADPKD-iPSCs is similar to podocytes and human kidney (HK2) cells. Bar = 100 μm. ( c ) Upregulation of marker genes of each stage during differentiation from iPSCs into functional KLCs. Values (mean of three replicates) are referred to the undifferentiated iPSCs. Data presented as mean ± standard deviation from three independent sets of experiments, * P < 0.05, ** P < 0.01. ( b ) Pluripotency of iPSCs decreased during induction to KLCs. Data are averages and standard deviations of three independent experiments. Values (mean of three replicates) are referred to the undifferentiated iPSCs. ** P < 0.01. ( e ) Immunofluorescence and FCM results of marker genes of each step of induction. BRY is a marker <t>of</t> <t>mesoderm</t> cells; PAX2 a marker for intermesoderm cells; and synaptopodin, AQP1, and E-cadherin (E-CAD) are markers for KLCs. Bar = 50 μm. iPSC induced pluripotent stem cell, RA <t>retinoic</t> acid, REGM renal epithelium growth medium, ABVF Activin-A, BMP7, hVEGF and bFGF
9 Cis Retinoic Acid Ra, supplied by AG Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/9+cis+retinoic+acid+ra/10__1074_slash_jbc__m607148200-60-9-12
Average 90 stars, based on 1 article reviews
9-cis-retinoic acid ra - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rabbit polyclonal anti-retinoic acid (ra)  (Abnova)
90
Abnova rabbit polyclonal anti-retinoic acid (ra)
Direct differentiation of ADPKD-iPSCs into kidney-like cells (KLCs). ( a ) Scheme showing the stepwise protocol used for producing KLCs from ADPKD-iPSCs and the time needed. ( b ) Morphology of induced ADPKD-iPSCs is similar to podocytes and human kidney (HK2) cells. Bar = 100 μm. ( c ) Upregulation of marker genes of each stage during differentiation from iPSCs into functional KLCs. Values (mean of three replicates) are referred to the undifferentiated iPSCs. Data presented as mean ± standard deviation from three independent sets of experiments, * P < 0.05, ** P < 0.01. ( b ) Pluripotency of iPSCs decreased during induction to KLCs. Data are averages and standard deviations of three independent experiments. Values (mean of three replicates) are referred to the undifferentiated iPSCs. ** P < 0.01. ( e ) Immunofluorescence and FCM results of marker genes of each step of induction. BRY is a marker <t>of</t> <t>mesoderm</t> cells; PAX2 a marker for intermesoderm cells; and synaptopodin, AQP1, and E-cadherin (E-CAD) are markers for KLCs. Bar = 50 μm. iPSC induced pluripotent stem cell, RA <t>retinoic</t> acid, REGM renal epithelium growth medium, ABVF Activin-A, BMP7, hVEGF and bFGF
Rabbit Polyclonal Anti Retinoic Acid (Ra), supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/rabbit+polyclonal+anti+retinoic+acid++ra+/10__1523_slash_jneurosci__2922___18__2019-148-183-189
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-retinoic acid (ra) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
9-cis-retinoic acid (ra  (Funakoshi ltd)
90
Funakoshi ltd 9-cis-retinoic acid (ra
Direct differentiation of ADPKD-iPSCs into kidney-like cells (KLCs). ( a ) Scheme showing the stepwise protocol used for producing KLCs from ADPKD-iPSCs and the time needed. ( b ) Morphology of induced ADPKD-iPSCs is similar to podocytes and human kidney (HK2) cells. Bar = 100 μm. ( c ) Upregulation of marker genes of each stage during differentiation from iPSCs into functional KLCs. Values (mean of three replicates) are referred to the undifferentiated iPSCs. Data presented as mean ± standard deviation from three independent sets of experiments, * P < 0.05, ** P < 0.01. ( b ) Pluripotency of iPSCs decreased during induction to KLCs. Data are averages and standard deviations of three independent experiments. Values (mean of three replicates) are referred to the undifferentiated iPSCs. ** P < 0.01. ( e ) Immunofluorescence and FCM results of marker genes of each step of induction. BRY is a marker <t>of</t> <t>mesoderm</t> cells; PAX2 a marker for intermesoderm cells; and synaptopodin, AQP1, and E-cadherin (E-CAD) are markers for KLCs. Bar = 50 μm. iPSC induced pluripotent stem cell, RA <t>retinoic</t> acid, REGM renal epithelium growth medium, ABVF Activin-A, BMP7, hVEGF and bFGF
9 Cis Retinoic Acid (Ra, supplied by Funakoshi ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/9+cis+retinoic+acid++ra/pmc10483283-55-58-62
Average 90 stars, based on 1 article reviews
9-cis-retinoic acid (ra - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
retinoic acid (ra)/ ifn combination trial  (Axxima Pharmaceuticals)
90
Axxima Pharmaceuticals retinoic acid (ra)/ ifn combination trial
Direct differentiation of ADPKD-iPSCs into kidney-like cells (KLCs). ( a ) Scheme showing the stepwise protocol used for producing KLCs from ADPKD-iPSCs and the time needed. ( b ) Morphology of induced ADPKD-iPSCs is similar to podocytes and human kidney (HK2) cells. Bar = 100 μm. ( c ) Upregulation of marker genes of each stage during differentiation from iPSCs into functional KLCs. Values (mean of three replicates) are referred to the undifferentiated iPSCs. Data presented as mean ± standard deviation from three independent sets of experiments, * P < 0.05, ** P < 0.01. ( b ) Pluripotency of iPSCs decreased during induction to KLCs. Data are averages and standard deviations of three independent experiments. Values (mean of three replicates) are referred to the undifferentiated iPSCs. ** P < 0.01. ( e ) Immunofluorescence and FCM results of marker genes of each step of induction. BRY is a marker <t>of</t> <t>mesoderm</t> cells; PAX2 a marker for intermesoderm cells; and synaptopodin, AQP1, and E-cadherin (E-CAD) are markers for KLCs. Bar = 50 μm. iPSC induced pluripotent stem cell, RA <t>retinoic</t> acid, REGM renal epithelium growth medium, ABVF Activin-A, BMP7, hVEGF and bFGF
Retinoic Acid (Ra)/ Ifn Combination Trial, supplied by Axxima Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/retinoic+acid+ra/retinoic+acid++ra+++ifn+combination+trial/pm15833066-75-17-2
Average 90 stars, based on 1 article reviews
retinoic acid (ra)/ ifn combination trial - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Characterization of blank NLC and ATRA-loaded NLC (NLC-A and NLC-B) for PCS diameter, polydispersion index and zeta potential.

Journal: Expert review of anticancer therapy

Article Title: Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid

doi: 10.1586/14737140.2015.1000868

Figure Lengend Snippet: Characterization of blank NLC and ATRA-loaded NLC (NLC-A and NLC-B) for PCS diameter, polydispersion index and zeta potential.

Article Snippet: 2.1 Materials All-trans retinoic acid (ATRA) and Compritol ® 888 ATO (glyceryl behenate, mixture of mono-, di-, and triacylglycerols of behenic acid [C 22 ]) were kindly provided by BASF (Ludwigshafen, Germany) and Gattefossé (Lyon, France), respectively.

Techniques: Zeta Potential Analyzer

Effects of different treatments on DNA fragmentation and cell-cycle phases distribution of the breast cancer (A; MCF-7 and MDA-MB-231) and leukemic cell lines (B; HL-60 and Jurkat).

Journal: Expert review of anticancer therapy

Article Title: Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid

doi: 10.1586/14737140.2015.1000868

Figure Lengend Snippet: Effects of different treatments on DNA fragmentation and cell-cycle phases distribution of the breast cancer (A; MCF-7 and MDA-MB-231) and leukemic cell lines (B; HL-60 and Jurkat).

Article Snippet: 2.1 Materials All-trans retinoic acid (ATRA) and Compritol ® 888 ATO (glyceryl behenate, mixture of mono-, di-, and triacylglycerols of behenic acid [C 22 ]) were kindly provided by BASF (Ludwigshafen, Germany) and Gattefossé (Lyon, France), respectively.

Techniques: Control

Direct differentiation of ADPKD-iPSCs into kidney-like cells (KLCs). ( a ) Scheme showing the stepwise protocol used for producing KLCs from ADPKD-iPSCs and the time needed. ( b ) Morphology of induced ADPKD-iPSCs is similar to podocytes and human kidney (HK2) cells. Bar = 100 μm. ( c ) Upregulation of marker genes of each stage during differentiation from iPSCs into functional KLCs. Values (mean of three replicates) are referred to the undifferentiated iPSCs. Data presented as mean ± standard deviation from three independent sets of experiments, * P < 0.05, ** P < 0.01. ( b ) Pluripotency of iPSCs decreased during induction to KLCs. Data are averages and standard deviations of three independent experiments. Values (mean of three replicates) are referred to the undifferentiated iPSCs. ** P < 0.01. ( e ) Immunofluorescence and FCM results of marker genes of each step of induction. BRY is a marker of mesoderm cells; PAX2 a marker for intermesoderm cells; and synaptopodin, AQP1, and E-cadherin (E-CAD) are markers for KLCs. Bar = 50 μm. iPSC induced pluripotent stem cell, RA retinoic acid, REGM renal epithelium growth medium, ABVF Activin-A, BMP7, hVEGF and bFGF

Journal: Stem Cell Research & Therapy

Article Title: Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation

doi: 10.1186/s13287-017-0645-8

Figure Lengend Snippet: Direct differentiation of ADPKD-iPSCs into kidney-like cells (KLCs). ( a ) Scheme showing the stepwise protocol used for producing KLCs from ADPKD-iPSCs and the time needed. ( b ) Morphology of induced ADPKD-iPSCs is similar to podocytes and human kidney (HK2) cells. Bar = 100 μm. ( c ) Upregulation of marker genes of each stage during differentiation from iPSCs into functional KLCs. Values (mean of three replicates) are referred to the undifferentiated iPSCs. Data presented as mean ± standard deviation from three independent sets of experiments, * P < 0.05, ** P < 0.01. ( b ) Pluripotency of iPSCs decreased during induction to KLCs. Data are averages and standard deviations of three independent experiments. Values (mean of three replicates) are referred to the undifferentiated iPSCs. ** P < 0.01. ( e ) Immunofluorescence and FCM results of marker genes of each step of induction. BRY is a marker of mesoderm cells; PAX2 a marker for intermesoderm cells; and synaptopodin, AQP1, and E-cadherin (E-CAD) are markers for KLCs. Bar = 50 μm. iPSC induced pluripotent stem cell, RA retinoic acid, REGM renal epithelium growth medium, ABVF Activin-A, BMP7, hVEGF and bFGF

Article Snippet: To initiate differentiation toward the intermediate mesoderm (IM), cells were cultured for another 7 days with retinoic acid (RA; HumanZyme) supplemented with stage 1 medium without Activin-A.

Techniques: Marker, Functional Assay, Standard Deviation, Immunofluorescence